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Abstract: The evaluation of pain in the newborn and the infant is difficult because pain is mainly a subjective phenome-
non. Until a few years ago, several myths persisted. First, the myth that children, especially infants, do not feel pain the 
way adults do, therefore there is no untoward consequences for them. Second, lack of assessment and reassessment for the 
presence of pain. Third, misunderstanding of how to conceptualise and quantify a subjective experience. Fourth, lack of 
knowledge of pain treatment. Fifth, the notion that addressing pain in children takes too much time and effort, in ultimate 
analysis resulting in wasting time. Sixth, fears of hidden -and not easy to diagnose or prevent- adverse effects of analgesic 
medications, including respiratory depression and addiction. Finally, from a conceptual point of view, high thresholds of 
pain in neonates and infants were considered to be present by natural character, and useful in protecting infant from pain 
during birth and transit through the narrow vaginal channel. 
The present review is focused on the description of different theories on the pain pathogenesis in children. 
INTRODUCTION 
  Prematures, neonates and older children have highly de-
veloped neuroanatomical and neurohumoral structures, and 
can feel pain at least as adults do. Moreover, from research 
investigation performed in both children and in laboratory 
animals, we know that in these phases of life several compo-
nents of the nervous, endocrine and other systems are still 
under a critical process of “programming”. In laboratory 
animals acute strong painful procedures, or even mild re-
peated procedures as some pain episodes are (e.g., repeated 
injections), may upset for long time or permanently some 
organs programming and functions, and partly similar effects 
were observed in the clinical practice [1, 2]. Therefore, the 
reasons for preventing and alleviating any forms of suffer-
ence to children appear to go far beyond the immediate tar-
get of avoiding pain, fear and distress. Sometimes, health 
structures show little understanding of adequate recognizing 
and facing problems related to children pain. Therefore, at 
least two priorities appear to exist in this field: First, educa-
tional priority. Training programmes for health-care workers 
should contain essential guidelines for relieving pain in chil-
dren. Second, organizative priority. The staff of every hospi-
tal and cancer unit should include individuals with expertise 
in pain management. Integrated organizative units for pallia-
tive care should be finally recognized as an integral part of 
severe health problems care (e.g, cancer) in children. 
  Quite recently, all these statements were discussed and 
abated from different points of view. Anatomic and physiol-
ogic nociceptive pathways, although still developing, are in 
place in premature neonates as young as at 26 weeks of ges-
tation, and several peripheral and central nervous system 
structures involved in nociception develop during the second 
and third trimester of gestation; moreover, although myelini- 
zation has not been fully estabilished by this time, it will 
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only result in lesser speed of nociceptive transmission when 
compared to adult. Such reduction of information process-
ing, however, is fully compensated by the shorter length of 
nerve layers to pain-modulating center in the central nervous 
system (CNS) [3-5]. Also synthesis of most neurotransmit-
ters involved in pain sensitivity and modulation occurs early 
in human development, for example substance P or Beta-
endorphin are produced as early as at the 15
th-20
th weeks of 
gestation [6, 7]. Therefore, although no neonates or infants 
can describe their pain sensitivity in current language, we 
know that most of their anatomical and neurochemical struc-
tures at these ages can produce stressful and unpleasant ef-
fects as strong and persistent as they do in other ages of life, 
and perhaps even more. Often, newborns are exposed to pain 
experiences such as blood sampling, immunization, vitamin 
K injection, or circumcision without receiving adequate an-
algesia or sedation procedures. These and other painful expe-
riences should be avoided whenever possible. During the last 
few years both clinical and preclinical evidences were pro-
duced to better understand long-term effects induced by 
early stressful procedures, and these effects can represent the 
“memory” of pain. For example, circumcision performed at, 
or shortly after birth without analgesic procedures alters the 
infant response to successive pain, evaluated during vaccina-
tions shots performed a few months later [8]. Moreover, 
other studies showed that 18-month-old former prematurely-
born extremely low birth weight infants, who spent the first 
few weeks of their life in neonatal intensive care units, were 
rated by their parents as much less behaviourally sensitive, 
compared to their term-born normal birth weight peers [9]. 
These data were confirmed by others [10]. 
  Even stronger and more detailed evidences were pro-
duced by experimental laboratory investigation. Information 
collected from experimental animals showed that even mild 
but repetitive neonatal painful experiences (such as the one 
caused by a needle puncture) may cause long-term or perma-
nent alterations of pain sensation, through interference with 
mechanisms connected to the developmental plasticity of the 
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chemical structures, as for example the opioid receptors sen-
sitivity [11, 12]. In fact, these stressful procedures adminis-
tered within a critical window of increased sensitivity of 
biochemical structures to environmental changes, during 
specific structure synthesis periods in the developing brain, 
named “critical periods” of development may produce long-
term or permanent alterations of said structures or functions. 
Moreover, effects of repetitive pain procedures coupled to 
repeated brief-lasting maternal separation during lactation 
period in rodents go far beyond pain sensitivity alteration. 
Rodent pups which in the neonatal period are exposed to 
these slight stressful procedures (daily saline subcutaneous 
injection plus 10 minutes deprivation from mother, up to 
weaning), display as adults a variety of behavioural, meta-
bolic, hormonal and physiologic alterations. For example, 
they show enduring alterations of the immune system, con-
sistent increase of body weight and upsetting of visceral fat 
distribution, accompanied by alteration of glucidic and 
lipidic metabolic parameters, alteration of hypothalamus-
pituitary-adrenal axis hormones feedback control mecha-
nisms, and alterations of brain hippocampus neurophysi-
ological parameters, indicating chronic derangement of brain 
plasticity modulation mechanisms [13-15] Table 1. Ruda et 
al. [16] studied a model of long-term effects of neonatal pain 
based on intraplantar hindpaw injection of complete Fre-
und’s adjuvant, and showed that when adults, in these rats 
which underwent further inflammation, the dorsal horn of 
the spinal cord on the side ipsilateral to the site of the previ-
ous neonatal inflammation, expressed significantly higher 
density of Fos-immuno-reactive neurons as compared to that 
on the contralateral side. Therefore, animal experiments are 
of great help in the understanding that children’s sensitivity 
to pain, and to pain-inducing procedures, should be viewed 
with greater attention by our mind, not only for the immedi-
ate elimination or assuaging pain and suffering whenever 
possible, but also for attenuating long-term or permanent 
consequences in the adult’s life, possibly induced by stress 
and cascade consequences triggered by pain. 
TYPES OF PAIN IN CHILDREN 
  Neurobiology of pain in children has peculiar develop-
mental aspects; repeated or strong pain experiences may in-
clude stress-induced hormonal derangements which may 
produce prolonged structural and functional alterations in 
pain pathways that can last into adult life [17, 18]. Besides, 
most types of pain in children can be classified under the 
same taxonomy as adults, with differences in the relative 
prevalence and incidence of the various types [19-21]. Al-
though pain classes are not diagnoses, categorizing pain 
helps guide treatment. Several systems for classifying pain 
exist. These include multidimensional classification systems, 
such as the IASP Classification of Chronic Pain [22] and a 
variety of systems based on a single dimension of pain expe-
rience. Of the latter systems, those based on pain duration 
(i.e., acute v/s chronic pain) and underlying pathophysiology 
i.e., nociceptive v/s neuropathic pain) are used most often. 
Epidemiological data have been produced, but usually these 
are related to specific information. An example of data is 
added in the following Box 1: 
-  Over one-third of school-age children will sustain injuries severe 
enough to be treated by a doctor or nurse. The yearly costs have been 
estimated to be 1.8 billion US$ [24] 
-  Traumatic injuries occur in more than 20 million US children each 
year, and are the leading source of death in children over the age of 1 
year [25] 
-  Prevalence of children who ever experienced toothache ranges from 5 
to 33% [26] 
-  Headache in pediatric population is substantially underdiagnosed. 
Studies indicate an overall prevalence of 8 up to 60% in various chil-
dren and adolescent populations [27] 
-  Accurate prevalence of severy ill children with life-limiting condi-
tions in need of palliative care is not available, but figures are tending 
to converge on 10 per 10000 children aged 0-19 per annum [28] 
Box 1. 
PAIN ASSESSMENT 
  Infant pain assessment is not universally standardized. 
Several specialists and clinicians associations insist on a 
concept of pain which is also comprehensive of a wider vi-
sion of children’s health and environment control. This con-
cept was well summarized in the title of the paper “Preven-
tion and management of pain and stress in the neonate” [29], 
and includes two of the main priciples in this field. The first 
is that pain must be prevented in each of its various aspects 
whenever possible. The second, that pain is a strong stressful 
procedure, and is accompanied and followed (and often pre-
ceeded as in the case of procedural pain) by a constellation 
of behavioural and pathophysiologic reactions inside the 
organism (Table 2).  
Table 1.  Types of Pediatric Pain 
Acute pain  
Procedure-related pain 
Peri-operative pain 
Burns 
Trauma 
Acute illness 
Cancer pain 
Tumor-related pain 
Therapy-related pain  
Chronic non-malignant pain 
Headaches 
Juvenile rheumatoid arthritis 
Chronic abdominal pain 
Haemophilia 
Sickle cell disease 
Chronic debilitating diseases 
Reflex sympathetic dystrophy 
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Table 2.  Markers Used to Indicate Pain in Neonates 
Cardiorespiratory 
Increase in heart rate 
Increase in blood pressure 
Increase in respiratory rate 
Fall in trancutaneous oxygen concentration 
Sweat gland 
Increase in palmar sweating 
Increase in electrical conductance of the skin 
Hormonal 
Increased plasma concentrations 
Cortisol 
Catecholamines 
Renin activity and aldosterone 
Growth hormone 
Glucagon 
Suppression of insulin secretion 
Behavioural 
Changes in facial expression  
Onset and duration of crying (or in some cases, stopping of crying) 
Flexor withdrawal of limb 
(Modified from Chiswick, 2000) [30]. 
Consequences of Pain in Infants 
Immediate effects 
•  Fear 
•  Irritability 
•  Disturbance of sleep and wakefulness state 
•  Increased oxygen consumption 
•  Ventilation-perfusion mismatch 
•  Diminished nutrient intake 
•  Increased gastric acidity 
Short term effects 
•  Impaired emotional bonding 
•  Altered immunological function 
•  Delayed healing 
•  Enhanced catabolism 
Long term effects 
•  Alteration in response to subsequent painful experience 
•  Developmental retardation 
•  Memory of pain 
(Modified from Mathew and Mathew, 2003) [31]. 
  Because of the varying capabilities of communication, 
age-appropriate pain assessment tools are needed to facilitate 
accurate appraisal, i.e., in neonates, infants, toddlers, chil-
dren. The three major modalities to pain assessment are: self-
reports, behavioural observation, and monitoring of physio-
logical parameters [32-37].  
  Pain can be assessed using self-report, because pain is a 
subjective experience. This method is to be applied in the 
case of mature children. Children have to accurately report 
on the location, sensory quality, intensity, affective elements 
and tolerability of pain. Because of the general skepticism of 
self-reports of pain from children, health care professionals 
sometimes tend to depreciate the validity of a child’s pain 
complaints. These however may be of the greatest help [32-
37].  
  When communication is not possible, for children who 
are too young to understand the use of self-report scales, and 
children with cognitive impairment and/or physical handi-
caps, is necessary to resort to behavioural observation. Be-
havioural responses to pain change with the age and often 
with the type of pain (e.g., acute versus chronic), and follow 
a developmental trend. Therefore, several behavioural and 
physiological measurement tools were developed to assess 
pain in infants and nonverbal children; most useful parame-
ters are: vocalization/ verbalization, facial expression, body 
language, and emotional state. The reliability and validity of 
behavioural observations are highest when the pain being 
measured is short in duration and acute in nature, such as 
pain associated with medical procedures. Facial expression 
has been found to be one of the most consistent indicators of 
pain. Components include brow bulge, eye squeeze, nasola-
bial furrow, open lips, vertical stretch mouth, horizontal 
stretch mouth, lip purse, taut tongue, and chin quiver [32-
37]. 
  Parents/caretakers are the most consistent persons caring 
for a child and usually know what behaviors signal pain and 
what measures may comfort their child. Parents should be 
encouraged to participate in their child’s pain assessment and 
management. This participation will not only benefit the 
child, but also give them a sense of control and help [32-37]. 
Children’s pain and distress can be evaluated with the aid of 
objective physiological measures. Those parameters that 
have been tested as pain measures include heart rate, respira-
tion rate, blood pressure, palmar sweating, cortisol levels, 
vagal tone, and endorphin concentrations. Other physiologic 
responses to pain include pupil dilation, flushing or pallor, 
nausea, and decrease in oxygen saturation. Many of these 
parameters have been incorporated into behavioral scales to 
form a more comprehensive assessment in infants and non-
verbal children [38, 39]. 
  Frequently used assessment scales include those in Box 
2.  
  Procedural pain (e.g., bone marrow biopsies, lumbar 
punctures or wound care and so on) is usually brief and can 
be a daily occurrence. These encounters, despite their brev-
ity, can be traumatic. To prevent suffering, multiple modali-
ties may be required. Current considerations suggest the im-
plementation of imagery and distraction, since these tech-
niques have been shown to be effective in children. The use 
of topical analgesics lessens the trauma of many procedures, Neurobiology of Pain in Children  The Open Biochemistry Journal, 2009, Volume 3    21 
and the affective interaction with mother may prevent or 
attenuate some sequelae of stressful procedures. Sedation 
units afford safe completion of procedures with minimal 
duress for the child.  
  An increase in pulmonary artery pressure and an increase 
in the level of stress hormones such as ACTH, adrenaline, 
noradrenaline, corticosteroids, glucagon and aldosterone is 
seen when painful stimuli are inflicted upon neonates under-
going surgery without sufficient analgesia Table 3. 
PHARMACOLOGICAL INTERVENTION 
  Analgesic drugs to be used in children are the same as for 
adults, and are administered using analogous procedures, but 
in the prevention and management of pediatric pain there are 
some important differences and general rules. The preferred 
administration routes are oral and rectal. Pain caused by in-
travenous and subcutaneous or intramuscular injection may 
be alleviated through the use of topical analgesic ointment. 
Pain should be prevented whenever possible, and in case of 
chronic pain analgesics should be administered according to 
a time programming, and not as needed. This approach saves 
children from suffering, requires lower doses of analgesic 
and lowers the possibility of tolerance effects. In the Box 3 
some recommendations for pain treatment are reported. 
  The “analgesic ladder” for pain management proposed by 
the WHO [40], consists of a three-steps approach to pain 
treatment. Pain is classified as mild, moderate or severe, and 
analgesic choices are adjusted accordingly. The sequential 
use of analgesic drugs is based on the child’s level of pain, 
and the first step in controlling mild pain is a non-opioid 
analgesic. If pain persists, an opioid for mild to moderate 
pain should be given together with non-opioid drug, if ap-
propriate, for supplementary analgesia (step 2). When a 
weak opioid combined with a non-opioid fails to provide 
relief, an opioid for moderate to severe pain should be sub-
stituted (step 3). Morphine is the drug of choice in this in-
stance. Again, non-opioid analgesics may be continued, and 
adjuvant drugs may be given for specific indications, accord-
ing to the following scheme: 
1)  Non-steroidal anti-inflammatory drugs (NSAIDS) and 
paracetamol, with or without adjuvant drugs. Most 
common uses include acute pain, peri-surgical pain, 
headache, musculo-skeletal conditions. Most common 
Based on Behavioural Change 
•  Neonatal Facial Coding System (NFCS) 
•  Infant Body Coding System (IBCS) 
•  Neonatal Infant Pain Scale (NIPS) 
•  Pain assessment in Neonates (PAIN) 
•  Liverpool Infant Distress Scale (LIDS) 
•  Modified Behavioural Pain Scale  
•  Children’s Hospital of Eastern Ontario Pain Scale (CHEOPS) 
•  Neonatal assessment of Pain Inventory (NAPI) 
•  Behavioural pain score 
•  Clinical scoring system 
Combination of physiological and behavioural changes 
•  CRIES (i.e., crying, change in transcutaneous oxygen satura-
tion, heart rate, blood pressure, facial expression and alteration 
in sleep pattern). 
•  Pain Assessment Tool (PAT) 
•  Premature Infant Pain Profile (PIPP) 
•  Scale for Use in Newborns (SUN) 
•  COMFORT Score 
(Modified from Mathew and Mathew, 2003) [31]. 
Box 2.  Pain Assessment Scales In Infants 
Table 3.  Markers Frequently Used to Indicate Pain in the Neonate 
  Premature Infant Pain Pro-
file 
Neonatal Facial Coding 
Scale (NFCS) 
Neonatal Infant Pain 
Scale (NIPS) 
CRIES Score 
Variables assessed  Gestational age Behaviour 
Heart rate  
Oxygen saturation  
Brow bulge  
Eye squeeze  
Nasolabial furrow  
Brow bulge  
Eye squeeze 
Nasolabial furrow  
Open lips 
Stretch mouth 
Lip purse  
Taut tongue  
Chin quiver 
Tongue protrusion  
Facial expression  
Cry 
Breathing patterns 
Arms 
Legs 
Arusal condition  
Crying 
Requires increased oxygen admini-
stration 
Increase of vital signs 
Expression 
Sleeplessness 
Reliability   Inter- and intrarater reliability 
>0.93 
Inter- and intrarater reli-
ability >0.85 
Interrater reliability >0.92  Interrater reliability >0.72 
Clinical utility  Feasibility and utility estab-
lished at bedsite 
Feasibility established at 
bedsite 
Not established   Nurses preferred CRIES over another 
scale 
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substances, and recommended doses per os are: ibu-
profen (5-10 mg/kg every 6-8 h); diclofenac (1 mg/kg 
every 6-8 h); naproxen (5 mg/kg every 8-12 h); 
paracetamol (10-15 mg/kg, every 6-8 h). Paracetamol 
has scarce or no gastrointestinal or haematological 
side effects, but lacks anti-inflammatory activity.  
2)  Weaker opioids, with or without adjuvant drugs or 
NSAIDS. Most common substances are: codeine (0.5-
1 mg/kg every 3-4 h for children over 6 months of 
age); hydrocodone (0.2 mg/kg every 3-4 h); oxy-
codone (0.2 mg/kg every 3-4 h), all given per os. 
3)  Strong opioids, with or without non-opioids and adju-
vant drugs. Morphine recommended oral dose is 0.3 
mg/kg every 3-4 h (parenteral 0.1 mg/kg); buprenor-
fine recommended parenteral dose is 0.004 mg/kg 
every 6-8 h). Fentanyl, usual iv or sc starting dose 
0.5-2 micrograms/kg per h as continue infusion. 
  Adjuvant medication that are used in conjunction with 
analgesics often potentiate their analgesic effect. These in-
clude antihistamines (diphenhydramine, hydroxyzine, indi-
cated for opioid-induced pruritus, nausea); tricyclic antide-
pressants (imipramine, amitriptyline, indicated for neuro-
pathic pain, insomnia); anticonvulsants (gabapentin, carba-
mazepine, indicated for neuropathic pain, especially shooting 
or stabbing pain); psycostimulants (methylphenidate, am-
phetamine, indicated for opioid-induced somnolence, poten-
tiation of opioid analgesia); corticosteroids (prednisone, dex-
amethasone, for headache from raised intracranial pressure, 
spinal or nerve compression, widespread metastases), and 
others. Procedural pain may be prevented with local analge-
sia, or when required with a combination of drugs which 
includes an anxyolitic (e.g., midazolam, lorazepam), with an 
opioid (e.g., fentanyl). In operating rooms or emergency 
rooms general anesthetic agents can be used (e.g., ketamine, 
usually administered in combination with atropine and mida-
zolam, to prevent secretions and spasms). Other agents are 
propofol, or inhalation agents as nitrous oxide.  
  Several studies have shown the efficacy of cognitive-
behavioural therapy interventions for decreasing anxiety and 
distress related to procedural pain in children [41, 42].  
PAIN AND GENDER 
  Unfortunately, too often differences between males and 
females are not considered in laboratory research and in 
clinical practice, and instead are either ignored or statistically 
averaged. It is no longer controversial to suggest that there 
may be important differences between males and females in 
the perception and experience of pain. Research suggests that 
women are more vulnerable towards experiencing a greater 
number of pain episodes across the lifespan, in more bodily 
areas and with greater frequency than men [43].  
  Therefore, in puberal adolescents we can tackle the varia-
tion between and within boys and girls in the experience of 
visceral pain, headache, musculoskeletal pain, and quality of 
life [44, 45]. Investigations focused also on difference be-
tween males and females in opioid analgesia, from both ex-
perimental and clinical approaches [46]. However, data on 
pain sensitivity and on analgesic effects of various drugs in 
male and female prepuberal subjects, in human or laboratory 
animal species, are still scanty.  
POSSIBLE LONG-TERM EFFECTS INDUCED BY 
PAIN AND DRUG USE 
  Possible long-term alterations on nervous system plastic-
ity and on the neonatal programming of endocrine structures 
induced by stressful experiences, as strong pain or repeated 
mild pain are, are described in the Introduction paragraph. 
Such effects, and studies about pharmacological and non-
pharmacological tools to prevent or reduce them, are beyond 
the limits of our paper, and involve also experimental hy-
potheses which are still far from clinical application, there-
fore they shall not be dealt with.  
  Another important topic, namely the development of tol-
erance or physical dependence with repeated use, is a charac-
teristic feature of all the opioid drugs. Tolerance and de-
pendence are physiological responses seen in all patients, 
and are not predictors of addiction (hereby we remember that 
addiction is a behavioural pattern characterized by compul-
sive use of a drug and overwhelming involvement with its 
procurement and use). These processes, tolerance, depend-
ence and addiction, appear to be quite distinct. For example, 
cancer pain often requires prolonged treatment with high 
doses of opioids, leading to tolerance and dependence. Yet, 
abuse in this setting is very unusual, whereas abuse is seen 
when opioids are assumed for non-medical purposes. There-
fore, neither the presence of tolerance and dependence, nor 
the fear that they may develop should ever interfere with the 
appropriate use of opioids [47].  
  Pain in children is often unrecognized and undertreated, particularly in neonates. At any ages prematures, neonates and children do feel pain, and 
require analgesia as adults do 
  If a medical procedure is painful in adults, it must be considered painful in children 
  Newborns may experience a greater sensitivity to pain, and are much more susceptible to the long-term effects of pain, compared to older children 
and adults 
  Adequate treatment of pain may be associated with decreased clinical complications and decreased mortality 
  The appropriate use of pharmacological devices, associated to non pharmacological tools, prevent, reduce or eliminate pain in most clinical  
situations 
  Sedation should be administered with care: it may, or it may not alleviate pain, but may mask children’s behavioural response to pain 
  Clinical units should develop written guidelines and protocols for the managements of pain in neonates and children  
(Modified from Anand et al. 2001) [33]. 
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LONG-TERM PAIN AND PAIN DURING TERMINAL 
CARE  
  It is suggested that in a health district of 250000 people, 
with a child population of approximately 50000, in one year, 
50 children are likely to have a life-limiting condition, about 
half of whom will need active palliative care at any one time, 
and 5 are likely to die of  
a life-limiting condition, and of these, 
-  2 will die from cancer 
-  1 of heart disease 
-  2 of other life-limiting condition 
(modified from Anonymous, 1997) [28]. 
  Existing knowledge provides a basic approach for reliev-
ing cancer pain and chronic pain that can be implemented in 
developed and developing countries alike. Children with 
cancer or with severe life-limiting conditions do not need to 
suffer unrelieved pain. Effective pain management and pal-
liative care are among major priorities of the WHO cancer 
programme. Pain management must begin when a child is 
first diagnosed with cancer and must continue throughout the 
course of the illness. Analgesic and anaesthetic drug thera-
pies are essential in controlling pain and should be combined 
with appropriate psychosocial, physical, and supportive ap-
proaches to this problem [48].  
  In developed countries cancer is the leading cause of 
death from disease in 1-14 year-olds; approximately a figure 
of 70% of children can be cured if the disease is diagnosed 
early and appropriately treated, depending on the diagnosis 
type and precocity. Most children who live in developing 
countries do not receive curative therapies: often the disease 
is advanced by the time of diagnosis and curative therapies 
are frequently unavailable, or peoples cannot afford them. 
Countries differ widely in their diagnostic capabilities and 
reporting systems, however data in developed countries indi-
cate that all children with cancer do experience disease- or 
treatment-related pain, with more than 70% of them suffer-
ing from severe pain at some point. Although the means ex-
ist for its effective relief, children’s pain is often not recog-
nized or, if recognized, may be inadequately treated, even 
when sufficient resources are available [49, 50].  
 In  Table  4 are depicted the expenses for opioid drugs in 
11 of the European Countries, normalized in percent over the 
total drugs expense, in the whole population. Opioid drugs 
expenses are good parameters indicating the quality of can-
cer chronic pain therapy. Ratio between the highest users 
(Ireland and UK) and lowest users (Italy and Portugal) is in 
the order of 7.3. 
  Unrelieved pain places a heavy burden on children and 
families, and also on medical structures:  
-  Children become afraid of actual and future pain, and 
develop mistrust and fear of hospitals, medical staff 
and treatment procedures. 
-  Parents and other relatives often feel angry and dis-
trustful towards the medical system, and experience 
depression and guilt about being unable to prevent the 
pain. 
-  Poorly managed pain affects health careworkers: it 
numbs their compassion, creates guilt, and encour-
ages denial that children are suffering.  
  Comprehensive care of children with cancer or other life-
limiting diseases includes curative therapies, pain manage-
ment, and symptoms control, plus compassionate support 
both for the children and for their families. Parents and chil-
dren require special psychosocial and spiritual support to 
help them learn to live with cancer. In some specialized cen-
ters, this type of support is provided from the time of diagno-
sis throughout the child’s medical care. Other centers con-
tinue to focus exclusively on the medical management of the 
disease and show little understanding of adequate recogniz-
ing and facing all other problems, mainly analgesia, psycho-
social and spiritual support. However, such an approach, i.e., 
global approach to child’s needs, is central to the concept of 
palliative care, and should be part of any health structure 
which is devoted to admit and cure children. Often there is 
wide gap between what is known and what is practised; 
health-care workers may lack information about pain sys-
tems, metods of pain assessment, and effective means of 
relieving mild to severe and cancer pain. Therefore, at least 
two priorities appear to exist in this field: 
  First, educational priority. Training programmes for 
health-care workers should contain essential guidelines for 
relieving pain in children.  
  Second, organizative priority. The staff of every hospital 
and cancer unit should include individuals with expertise in 
pain management. Moreover, integrated organizative units 
for palliative care should be recognized as an an integral part 
of cancer care, and should make provision for psychosocial 
support for the family, who are the child's primary care-
givers. Additional support is essential for the family of a 
dying child. Specialized home-care agencies, hospices, res-
pite care homes, and palliative care units in hospitals may be 
considered for further assistance where needed.  
  Complete understanding of these problems include also 
pain assessment and pain treatment during the dying process. 
Table 4.  Opioid Drugs Expenses in European Countries (Ex-
pressed in % of Total Expense for all Drugs) 
1) Ireland 2.17 
2) UK 2.05 
3) Germany 1.89 
4) Austria 1.63 
5) France 1.52 
6) Finland 0.74 
7) Spain 0.73 
8) Belgium 0.69 
9) Greece 0.51 
10) Italy 0.30 
11) Portugal 0.28 
(From WHO, 1990) [40]. 24    The Open Biochemistry Journal, 2009, Volume 3  Loizzo et al. 
A search of the literature on this subject resulted in only a 
few publications. However, the last period of life of a child 
suffering from cancer is of crucial importance not only for 
the child himself but fur his parents and relatives as well. 
The way the child dies will remain in the memory of his par-
ents for ever. Multiple problems in management of dying 
child may arise during the last phase. Once again, a palliative 
care team consisting of medical and psychosocial staff, can-
not avert approaching death, but can make it as peaceful and 
as free of suffering as possible [51, 52].  
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